Table 1.
Details of baseline characteristics of all clinical samples
| Sample | Age(years) | Gestational age(days) | Gravidity | Parity | HCG( ±) | Viable Fetus | Usage |
|---|---|---|---|---|---|---|---|
| Mifepristone1 | 37 | 38 | 2 | 1 | + | YES | IHC/IF |
| Mifepristone2 | 39 | 45 | 5 | 2 | + | YES | IHC/IF/HE |
| Mifepristone3 | 28 | 42 | 2 | 0 | + | YES | IHC/IF/HE |
| Mifepristone4 | 36 | 37 | 4 | 2 | + | YES | IHC/IF/HE |
| Mifepristone5 | 31 | 51 | 2 | 1 | + | YES | IHC/IF/HE |
| Mifepristone6 | 34 | 41 | 3 | 1 | + | YES | RT-qPCR/WB |
| Mifepristone7 | 34 | 40 | 2 | 1 | + | YES | RT-qPCR/WB |
| Mifepristone8 | 33 | 50 | 2 | 2 | + | YES | RT-qPCR/WB |
| Mifepristone9 | 23 | 54 | 1 | 0 | + | YES | RT-qPCR/WB |
| Mifepristone10 | 26 | 40 | 1 | 0 | + | YES | RT-qPCR/WB |
| Mifepristone11 | 39 | 42 | 3 | 2 | + | YES | RT-qPCR/WB |
| Mifepristone12 | 35 | 46 | 2 | 1 | + | YES | RT-qPCR/WB |
| Mifepristone13 | 32 | 42 | 2 | 1 | + | YES | RT-qPCR/WB |
| Mifepristone14 | 36 | 46 | 2 | 1 | + | YES | RT-qPCR/WB |
| Mifepristone15 | 26 | 43 | 1 | 0 | + | YES | RT-qPCR/WB |
| Mifepristone16 | 35 | 39 | 3 | 2 | + | YES | RT-qPCR/WB |
| Mifepristone17 | 41 | 42 | 4 | 2 | + | YES | HE |
| Mifepristone18 | 34 | 49 | 2 | 1 | + | YES | HE |
| Mifepristone19 | 25 | 39 | 1 | 0 | + | YES | HE |
| Mifepristone20 | 36 | 42 | 2 | 1 | + | YES | HE |
| Control1 | 30 | 52 | 1 | 0 | + | YES | IHC/IF |
| Control2 | 33 | 51 | 3 | 1 | + | YES | IHC/IF |
| Control3 | 36 | 41 | 1 | 0 | + | YES | IHC/IF |
| Control4 | 36 | 40 | 2 | 1 | + | YES | IHC/IF/HE |
| Control5 | 28 | 46 | 2 | 1 | + | YES | IHC/IF/HE |
| Control6 | 42 | 40 | 2 | 1 | + | YES | Explant/TSC/TO/RNA-seq |
| Control7 | 31 | 51 | 2 | 1 | + | YES | Explant/TSC/TO/RNA-seq |
| Control8 | 31 | 34 | 1 | 0 | + | YES | Explant/TSC/TO/RNA-seq |
| Control9 | 32 | 35 | 1 | 0 | + | YES | Explant/TSC/TO |
| Control10 | 33 | 47 | 2 | 1 | + | YES | Explant/TSC/TO |
| Control11 | 37 | 56 | 2 | 0 | + | YES | Explant/TSC/TO |
| Control12 | 33 | 40 | 2 | 1 | + | YES | Explant/TSC/TO |
| Control13 | 39 | 35 | 2 | 1 | + | YES | Explant/TSC/TO |
| Control14 | 43 | 54 | 2 | 1 | + | YES | RT-qPCR/WB |
| Control15 | 26 | 47 | 1 | 0 | + | YES | RT-qPCR/WB |
| Control16 | 35 | 39 | 2 | 1 | + | YES | RT-qPCR/WB |
| Control17 | 34 | 54 | 2 | 1 | + | YES | RT-qPCR/WB |
| Control18 | 35 | 42 | 3 | 2 | + | YES | RT-qPCR/WB |
| Control19 | 29 | 43 | 1 | 0 | + | YES | RT-qPCR/WB |
| Control20 | 41 | 39 | 3 | 2 | + | YES | RT-qPCR/WB |
| Control21 | 24 | 42 | 1 | 0 | + | YES | RT-qPCR/WB |
| Control21 | 24 | 42 | 1 | 0 | + | YES | RT-qPCR/WB |
| Control22 | 40 | 42 | 1 | 0 | + | YES | HE |
| Control23 | 28 | 54 | 0 | 0 | + | YES | HE |
| Control24 | 32 | 44 | 1 | 1 | + | YES | HE |
| Control25 | 31 | 54 | 2 | 2 | + | YES | HE |
| Control26 | 36 | 47 | 3 | 2 | + | YES | HE |
| Control27 | 37 | 45 | 5 | 2 | + | YES | HE |
Abbreviations: IF, immunofluorescence; HCG, human chorionic gonadotropin; IHC, immunohistochemistry; H&E: hematoxylin and eosin staining; RT-qPCR, quantitative real-time polymerase chain reaction; WB, western blot; TSC, trophoblast stem cell; TO, trophoblast organoid